Is Boston Scientific Corporation (BSX) a Buy, Sell, or Hold?
Boston Scientific Corporation
NYSE:BSX
$42.63 USD
-$2.02 (-4.52%)
- Volume
- 20.09M
- Average Volume
- 20.55M
- Market Capitalization
- $63.36B
- P/E Ratio
- 17.76
- Dividend Yield
- 0.00%
- Price Target
- $70.50
- Year High
- $109.50
- Year Low
- $42.25
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.90
Industry, Sector & symbol
| Stock Exchange | NYSE |
| CEO | Michael F. Mahoney |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Current Symbol | BSX |
| CUSIP | 101137107 |
| CIK | 0000885725 |
| Web | https://www.bostonscientific.com |
| Phone | 508 683 4000 |
| Currency | USD |
| Employees | 59000 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.43 |
| Payout Ratio | 0.00 |
| Current Ratio | 1.90 |
| Quick Ratio | 1.22 |
| Cash Ratio | 0.33 |
Sales & Book Value
| Annual Sales | $20.07B |
| Price / Sales | 3.07 |
| Cash Flow | 2.32 |
| Price / Cash Flow | 18.41 |
| Price / Book | 2.45 |
Price Target and Rating
| Average Stock Price Forecast | $70.50 |
| High Stock Price Forecast | $120.00 |
| Low Stock Price Forecast | $55.00 |
| Forecast Upside/Downside | -39.53% |
| Consensus Rating | Neutral |
| Rating Score(0-5) | 3 |
| Research Coverage | 44 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $1.94 |
| Trailing P/E Ratio | 17.76 |
| PEG Ratio | 0.24 |
| P/E Growth | 0.24 |
| Net Income | $2.89B |
| Net Margin | 17.24% |
| Pretax Margin | 18.15% |
| Return on Equity | 14.82% |
| Return on Assets | 8.01% |
Financials Score
| AltmanZ Score | 3.30 |
| Piotroski Score | 7.00 |
| Working Capital | 4.11B |
| Total Assets | 44.35B |
| Ebit | 4.26B |
| Market Cap | 66.48B |
| Total Liabilities | 18.25B |
Poll Results
About Boston Scientific Corporation (NYSE:BSX) Stock
Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management ... systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note
2026-07-14 19:01:15
In the latest trading session, Boston Scientific (BSX) closed at $42.63, marking a -4.52% move from the previous day.
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?
2026-07-10 10:30:38
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
'Selling Winners, Buying Losers': Tech Stocks Drop as Energy Jumps to Start H2
2026-07-09 15:45:03
A sharp rotation trade has taken over markets to start the second half of 2026, with investors dumping the year's biggest winners and piling into beaten-down names.
Billionaire Steve Cohen Sold Amazon and Nvidia but Loaded Up on This Beaten-Down Stock
2026-07-09 02:15:00
Amazon and Nvidia have been caught up in the AI trade, but have flatlined so far in 2026. Steve Cohen's Point72 Asset Management sold Amazon and Nvidia in the first quarter.
Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts
2026-07-06 19:17:14
Boston Scientific (BSX) closed at $44.6 in the latest trading session, marking a -1.2% move from the prior day.
Boston Scientific: The Time Has Come To Catch This Falling Knife
2026-07-06 11:59:49
Relative to its all-time high of $109.50 reached in September 2025, Boston Scientific Corporation's share price has declined by almost 60% to trade at around $45.00 per share. To put my money where my mouth is, I purchased my last shares on June 30th at an average price of $42.83. My overall purchase price now stands at $45.52. As part of its Q1-26 earnings, Boston Scientific announced a significant outlook revision, reducing its organic growth guidance for fiscal 2026 to a range between 6.5% and 8.0%.
Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note
2026-06-30 19:02:11
In the most recent trading session, Boston Scientific (BSX) closed at $42.68, indicating a -1.84% shift from the previous trading day.
Boston Scientific's Fall From Penthouse To Doghouse Creates A Value Opportunity
2026-06-25 13:18:10
Boston Scientific has suffered a 50% share price decline amid decelerating growth and competitive threats, but fundamentals-based valuation now appears attractive. Growth in key segments like electrophysiology and Watchman has slowed due to increased competition, reimbursement cuts, and less impressive clinical trial data. Management now guides to sub-10% revenue growth (6.5%-8% for the year), but I still expect 7.5% annualized growth over five years and improving margins.
Frequently Asked Questions
-
What is the current Boston Scientific Corporation (BSX) stock price?
-
Boston Scientific Corporation(NYSE:BSX) stock price is $42.63 in the last trading session. During the trading session, BSX stock reached the peak price of $109.5 while $42.25 was the lowest point it dropped to. The percentage change in BSX stock occurred in the recent session was --4.52% while the dollar amount for the price change in BSX stock was -$-2.02.
-
BSX's industry and sector of operation?
-
The NYSE listed BSX is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of BSX?
-
Adam Smith | General Manager of Global Sales & Marketing
Arthur Crosswell Butcher | Executive Vice President and Group President of MedSurg & Asia Pacific
Paudie O'Connor | Executive Vice President of Global Operations
Brenda Becker | Senior Vice President of Global Government Affairs
Emily Woodworth | Senior Vice President, Global Controller & Chief Accounting Officer -
How many employees does BSX have?
-
Number of BSX employees currently stands at 59000. BSX operates from 300 Boston Scientific Way, Marlborough, MA 01752-1234, US.
-
Link for BSX official website?
-
Official Website of BSX is: https://www.bostonscientific.com
-
How do I contact BSX?
-
BSX could be contacted at phone #508 683 4000 and can also be accessed through its website. BSX operates from 300 Boston Scientific Way, Marlborough, MA 01752-1234, US.
-
How many shares of BSX are traded daily?
-
The average number of BSX shares traded daily for last 3 months was 20.55M.
-
What is the market cap of BSX currently?
-
The market value of BSX currently stands at $63.36B with its latest stock price at $42.63